Combination therapy as initial treatment for newly diagnosed hypertension.
about
Imputing observed blood pressure for antihypertensive treatment: impact on population and genetic analyses.Clinical utility of fixed-dose combinations in hypertension: evidence for the potential of nebivolol/valsartan.Antihypertensive effect of mitochondria-targeted proxyl nitroxidesContribution of mitochondrial oxidative stress to hypertension.Current perspectives on combination therapy in the management of hypertension.Comparative effectiveness of antihypertensive therapeutic classes and treatment strategies in the initiation of therapy in primary care patients: a Distributed Ambulatory Research in Therapeutics Network (DARTNet) studyShould two-drug initial therapy for hypertension be recommended for all patients?The contribution of the ACCOMPLISH trial to the treatment of stage 2 hypertension.Sirt3 Impairment and SOD2 Hyperacetylation in Vascular Oxidative Stress and Hypertension.How does prescribing for antihypertensive products stack up against guideline recommendations? An Australian population-based study (2006-2014).Management of Hypertension in Primary Care Safety-Net Clinics in the United States: A Comparison of Community Health Centers and Private Physicians' Offices.Lower, faster, better: the delusions of surrogate markers in hypertension.Antihypertensive use before and after initiation of fixed-dose combination products in Australia: a retrospective study.Olmesartan-based monotherapy vs combination therapy in hypertension: A meta-analysis based on age and chronic kidney disease status.ARB-based single-pill platform to guide a practical therapeutic approach to hypertensive patients.
P2860
Q33598411-D8072903-05C0-4E80-BB56-C57CB8403472Q34609451-748D4F09-75EA-4855-9AD8-86DDB6EBF394Q35078160-DCD96078-34FD-4B4E-A33D-CCBDA54B9216Q36617393-2DE384EB-DC5A-4C7F-9663-14402D71697EQ36975801-637CE49C-6A86-470A-A57C-DDCE7B5414D3Q37569342-D6E48DF9-11A3-4117-96BA-C5BF7B33F407Q38015765-DA90B21A-EFE8-4FED-88D1-461F73E1D18AQ38182880-519C9EE1-A154-40D4-91F7-FAD1DB8A80B7Q38690310-FEB1DF99-833E-4030-9515-E17AFDD31D38Q39683030-DABE9F21-238E-4562-9FBA-CC3F3C9D6A6CQ39695053-EFA69A60-5D25-4BA9-A419-713EE8D52D10Q45655189-2B238DE0-AF99-4C6F-91D4-5811E70C1FA8Q45743672-EF2D1A9D-54A2-4334-82EB-DECE287D6458Q48131950-466AE8BB-7AB1-403D-8478-F4B28305CAACQ51752848-F78FB8D6-8FE4-4A73-BF57-1DE49D8560ED
P2860
Combination therapy as initial treatment for newly diagnosed hypertension.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Combination therapy as initial treatment for newly diagnosed hypertension.
@ast
Combination therapy as initial treatment for newly diagnosed hypertension.
@en
type
label
Combination therapy as initial treatment for newly diagnosed hypertension.
@ast
Combination therapy as initial treatment for newly diagnosed hypertension.
@en
prefLabel
Combination therapy as initial treatment for newly diagnosed hypertension.
@ast
Combination therapy as initial treatment for newly diagnosed hypertension.
@en
P2093
P2860
P50
P1476
Combination therapy as initial treatment for newly diagnosed hypertension
@en
P2093
David J Magid
Heather M Tavel
Joe V Selby
P Michael Ho
P2860
P304
P356
10.1016/J.AHJ.2011.05.010
P407
P577
2011-07-18T00:00:00Z